Inovio Pharma (INO) Tops Q2 EPS by 18c

Inovio Pharma (NASDAQ: INO) reported Q2 EPS of ($0.07), $0.18 better than the analyst estimate of ($0.25).

For earnings history and earnings-related data on Inovio Pharma (INO) click here.

You May Also Be Interested In

• North American Construction (NOA) Tops Q2 EPS by 9c; Offers Guidance
• Marchex (MCHX) Reports In-Line Q2 EPS
• CAE, Inc. (CAE) Tops Q1 EPS by 2c, Beats on Revenue; Offers FY27 EPS Guidance